Pasithea Therapeutics Corp. - Common Stock — Financial Statements (NASDAQ:KTTA) | MetaTrader

Open full chart Full chart

News

Pasithea Therapeutics Corp. (KTTA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript

Pasithea provides updates on clinical trials for MEK inhibitor drug

Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule

Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright

Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - CEA Industries (NASDAQ:BNC), Aditxt (NASDAQ:ADTX)

Crude Oil Gains 1%; Tilray Brands Shares Plunge - Rich Sparkle Holdings (NASDAQ:ANPA), HeartBeam (NASDAQ:BEAT)

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.67%

Why Pasithea Therapeutics (KTTA) Stock Is Suddenly On Fire Today - Pasithea Therapeutics (NASDAQ:KTTA)

Nasdaq Jumps Over 100 Points; Deere Shares Fall After Q4 Results - Amber International (NASDAQ:AMBR), Boqii Holding (AMEX:BQ)

ALS Association awards $1 million to study Pasithea’s PAS-004 in ALS

Why Keysight Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aurelion (NASDAQ:AURE)